Skip to content

easyEndoTM Lite Staplers and Loading Units in Thoracic Surgery

A Retrospective Study to Evaluate the Safety and Effectiveness of easyEndoTM Lite Staplers and Loading Units

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07345013
Enrollment
900
Registered
2026-01-15
Start date
2021-01-03
Completion date
2022-12-01
Last updated
2026-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic Surgery

Brief summary

A retrospective, single-arm, observation study to Evaluate the clinical safety and performance of Ezisurg stapler in thoracic surgery, 900 patients using the easyEndoTM Lite linear cutting stapler and loading units during thoracic surgery from 2021.03-2022.12 in Fujian Medical University Union Hospital. The surgical decision was made by the surgeons, and no other specification restrictions.

Interventions

DEVICEeasyEndoTM Lite linear cutting stapler and loading units

using the easyEndoTM Lite linear cutting stapler and loading units during thoracic surgery

Sponsors

Ezisurg Medical Co. Ltd.
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

The study population were patients using the easyEndoTM Lite linear cutting stapler and loading units during thoracic surgery from 2021.03-2022.12 in Fujian Medical University Union Hospital. The surgical decision was made by the surgeons, and no other specification restrictions.

Design outcomes

Primary

MeasureTime frameDescription
stapling success ratePerioperative/PeriproceduralNo intrate-operative and post-operative air-leak

Secondary

MeasureTime frame
Intraoperative blood lossPerioperative/Periprocedural
Rate of convert to open surgeryPerioperative/Periprocedural
Hospitalization timePerioperative/Periprocedural
Incidence of postoperative complicationsPerioperative/Periprocedural
Readmission rate30 days

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026